|4Feb 22, 4:32 PM ET

VASCULAR SOLUTIONS INC 4

4 · VASCULAR SOLUTIONS INC · Filed Feb 22, 2017

Insider Transaction Report

Form 4
Period: 2017-02-17
ROOT HOWARD
DirectorCEO
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17360,0000 total
    Exp: 2022-01-27Common Stock (360,000 underlying)
  • Disposition to Issuer

    Common Stock

    2017-02-17319,7720 total
Holdings
  • Common Stock

    319,772
Footnotes (5)
  • [F1]In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.
  • [F2]90,000 shares, which vested on January 27, 2014 with an exercise price of $12.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $43.97 per share, or $3,957,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
  • [F3]90,000 shares, which vested on January 27, 2015 with an exercise price of $13.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $42.97 per share, or $3,867,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
  • [F4]90,000 shares, which vested on January 27, 2016 with an exercise price of $14.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $41.97 per share, or $3,777,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.
  • [F5]90,000 shares, which vested on January 27, 2017 with an exercise price of $15.03 per share, were canceled pursuant to the Merger in exchange for a cash payment of $40.97 per share, or $3,687,300 in aggregate, which represents the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4